Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06088212

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor: the Cog-HF Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
168 (estimated)
Sponsor
Baker Heart and Diabetes Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will test the feasibility and effectiveness of an innovative model of care for cognitively impaired patients with heart failure. This program aims to improve cognition, reduce dementia risk and cardiovascular events, and will be supported by innovative digital technology for wide scale rollout and implementation. Findings from this research will transform the way healthcare is delivered to cognitively impaired patients with heart disease who have a very high risk of developing dementia.

Conditions

Interventions

TypeNameDescription
OTHERDisease management programThe components of our DMP include: 1. Intensive post-discharge education 2. Home surveillance of signs and symptoms will be reviewed (weekly in the first month and monthly thereafter) in a telehealth consultation with patient and/or carer. 3. Medical treatment involves a planned up-titration of cardioprotective medications that will proceed in the absence of advice from the general practitioner (GP) to the contrary. Close observation and frequent appointments are organised by the nurse with the patient's GP during up-titration period. 4. Exercise program delivered by an exercise physiologist 5. Maintenance phase of the DMP: During this maintenance phase, Intervention patients should have been fully transitioned to home care where they are managed by their GP at optimal doses of their medications. Repeated education and exercise guidance will continue with the carer, supported by our cardiac nurse and exercise physiologist via telehealth consultation bimonthly.

Timeline

Start date
2024-07-01
Primary completion
2025-10-01
Completion
2026-07-01
First posted
2023-10-18
Last updated
2024-08-12

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT06088212. Inclusion in this directory is not an endorsement.